CIK 0000711377 · Large accelerated filer
NEOGEN CORP
Sign in to watch- Ticker
- NEOG
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 382367843
- Phone
- 5173729200
- Business address
- 620 LESHER PLACE, LANSING, MI, 48912
- Open-market buys, last 90 days
- $6,035
- in 1 filing
- Open-market sales, last 90 days
- $114,676
- in 1 filing
Net −$108,641. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-28 | Jones Douglas Edward Chief Operating Officer | Shares withheld for taxes | −291 | $5.16 | $2K | 71,713 |
| 2025-04-28 | Jones Douglas Edward Chief Operating Officer | Option exercise · Restricted Stock Units | −845 | $5.16 | $4K | 1,690 |
| 2025-04-28 | Rocklin Amy M Chief Legal Officer | Option exercise | +564 | $5.16 | $3K | 36,851 |
| 2025-04-28 | Rocklin Amy M Chief Legal Officer | Option exercise · Restricted Stock Units | −564 | $5.16 | $3K | 1,128 |
| 2025-04-25 | Woteki Catherine E Director | Purchase | +5,770 | $5.17 | $30K | 13,244 |
| 2025-04-24 | BOREL JAMES C Director | Purchase | +30,000 | $4.99 | $150K | 90,474 |
| 2025-04-24 | BOEHM WILLIAM T Director | Purchase | +5,000 | $5.24 | $26K | 36,214 |
| 2025-04-24 | BOREL JAMES C Director | Purchase | +35,000 | $4.89 | $171K | 60,474 |
| 2025-04-23 | Rocklin Amy M Chief Legal Officer | Purchase | +12,500 | $4.99 | $62K | 36,287 |
| 2025-04-22 | CAPELLO JEFFREY D Director | Purchase | +20,712 | $4.84 | $100K | 26,629 |
Page 11 of 11 · 210 trades